Laurajo Ryan

444 total citations
18 papers, 338 citations indexed

About

Laurajo Ryan is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Laurajo Ryan has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Laurajo Ryan's work include HIV/AIDS Research and Interventions (5 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Laurajo Ryan is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Laurajo Ryan collaborates with scholars based in United States and Germany. Laurajo Ryan's co-authors include Christopher R. Frei, Kenneth A. Lawson, Rebecca L. Attridge, Antonio Anzueto, William D. Linn, Mary Jo Pugh, Russell T. Attridge, Eric M. Mortensen, Grace C. Lee and Marcos I. Restrepo and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Drugs.

In The Last Decade

Laurajo Ryan

18 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurajo Ryan United States	11	159	115	69	39	38	18	338
Csaba Fehér Spain	14	190 1.2×	119 1.0×	25 0.4×	44 1.1×	11 0.3×	23	482
Arne Mehl Norway	11	177 1.1×	70 0.6×	39 0.6×	32 0.8×	25 0.7×	13	374
Marina Esposito‐Farèse France	13	208 1.3×	56 0.5×	40 0.6×	61 1.6×	41 1.1×	21	552
Edgar Ortíz‐Brizuela Mexico	12	122 0.8×	263 2.3×	35 0.5×	24 0.6×	15 0.4×	36	420
Tracy L. Lemonovich United States	12	216 1.4×	137 1.2×	19 0.3×	21 0.5×	30 0.8×	17	455
Janet Wu United States	8	91 0.6×	97 0.8×	16 0.2×	40 1.0×	59 1.6×	13	360
Shirin Afhami Iran	12	104 0.7×	188 1.6×	24 0.3×	17 0.4×	16 0.4×	30	342
Anna Chiu United States	11	155 1.0×	261 2.3×	21 0.3×	21 0.5×	13 0.3×	15	542
Allison Bearden United States	6	70 0.4×	127 1.1×	19 0.3×	22 0.6×	39 1.0×	8	494
Jennifer E Girotto United States	12	143 0.9×	83 0.7×	14 0.2×	19 0.5×	21 0.6×	35	372

Countries citing papers authored by Laurajo Ryan

Since Specialization

Citations

This map shows the geographic impact of Laurajo Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurajo Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurajo Ryan more than expected).

Fields of papers citing papers by Laurajo Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurajo Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurajo Ryan. The network helps show where Laurajo Ryan may publish in the future.

Co-authorship network of co-authors of Laurajo Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Laurajo Ryan. A scholar is included among the top collaborators of Laurajo Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurajo Ryan. Laurajo Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ryan, Laurajo, et al.. (2023). Gender-affirming pharmacotherapy and additional health considerations: A contemporary review. Journal of the American Pharmacists Association. 63(6). 1669–1676.e1. 3 indexed citations

Ryan, Laurajo, et al.. (2021). Gut microbiome differences among Mexican Americans with and without type 2 diabetes mellitus. PLoS ONE. 16(5). e0251245–e0251245. 12 indexed citations

Ryan, Laurajo, et al.. (2019). National ambulatory care non-insulin antidiabetic medication prescribing trends in the United States from 2009 to 2015. PLoS ONE. 14(8). e0221174–e0221174. 15 indexed citations

Ryan, Laurajo, et al.. (2018). Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012. PLoS ONE. 13(11). e0206893–e0206893. 31 indexed citations

Attridge, Russell T., Christopher R. Frei, Mary Jo Pugh, et al.. (2016). Health care–associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes. Journal of Critical Care. 36. 265–271. 17 indexed citations

Corral, Mitra, John R. Penrod, Ying Zhang, et al.. (2014). New drugs not major cost drivers for lung cancer care. The American Journal of Managed Care. 6(3). 1 indexed citations

Reveles, Kelly R., et al.. (2014). How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. Journal of the American Pharmacists Association. 54(4). 441–445. 10 indexed citations

Attridge, Rebecca L., et al.. (2013). Fenofibrate-associated nephrotoxicity: A review of current evidence. American Journal of Health-System Pharmacy. 70(14). 1219–1225. 47 indexed citations

Ryan, Laurajo, et al.. (2013). Influence of Serum and Albumin on Echinocandin In Vitro Potency and Pharmacodynamics. Current Fungal Infection Reports. 7(2). 89–95. 9 indexed citations

10.

Wiederhold, Nathan P., et al.. (2012). Antibacterials as Adjuncts to Incision and Drainage for Adults with Purulent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections. Drugs. 72(3). 339–351. 11 indexed citations

11.

Faust, Andrew C., Rebecca L. Attridge, & Laurajo Ryan. (2011). How Low Should You Go? The Limbo of Glycemic Control in Intensive Care Units. Critical Care Nurse. 31(4). e9–e18. 6 indexed citations

12.

Oramasionwu, Christine U., Carolyn M. Brown, Kenneth A. Lawson, et al.. (2011). Differences in National Antiretroviral Prescribing Patterns Between Black and White Patients with HIV/AIDS, 1996–2006. Southern Medical Journal. 104(12). 794–800. 8 indexed citations

13.

Attridge, Russell T., Christopher R. Frei, Marcos I. Restrepo, et al.. (2011). Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. European Respiratory Journal. 38(4). 878–887. 92 indexed citations

14.

Attridge, Rebecca L., William D. Linn, Laurajo Ryan, Jim M. Koeller, & Christopher R. Frei. (2011). Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity. Journal of clinical lipidology. 6(1). 19–26. 18 indexed citations

15.

Oramasionwu, Christine U., Jeff Skinner, Laurajo Ryan, & Christopher R. Frei. (2009). Disparities in Antiretroviral Prescribing for Blacks and Whites in the United States. Journal of the National Medical Association. 101(11). 1140–1148. 6 indexed citations

16.

Oramasionwu, Christine U., Jeff Skinner, Laurajo Ryan, et al.. (2009). Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infectious Diseases. 9(1). 127–127. 20 indexed citations

17.

Oramasionwu, Christine U., et al.. (2009). HIV/AIDS Disparities: The Mounting Epidemic Plaguing US Blacks. Journal of the National Medical Association. 101(12). 1196–1204. 21 indexed citations

18.

Oramasionwu, Christine U., Carolyn M. Brown, Kenneth A. Lawson, Laurajo Ryan, & Christopher R. Frei. (2009). Evaluating HIV/AIDS Disparities for Blacks in the United States: A Review of Antiretroviral and Mortality Studies. Journal of the National Medical Association. 101(12). 1221–1229. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact